[Research Advances in Treatment of Myeloma Nephropathy-Review]

Xiao-Ping Zhang1, Zu-Yao Xia1, Bao-An Chen1

  • 1Department of Hematology and Oncology, Zhongda Hospital,Medical School, Southeast University, Nanjing,210009, Jiangsu Province, China.

Insights

Multiple myeloma (MM) can cause kidney damage (myeloma nephropathy) due to light chain buildup. This review highlights recent treatment advances for MM-related renal failure.

Area of Science:

  • Nephrology
  • Hematology
  • Internal Medicine

Background:

  • Myeloma nephropathy is a frequent complication in multiple myeloma (MM) patients.
  • Renal impairment is primarily caused by light chain cast nephropathy, leading to kidney obstruction.

Purpose of the Study:

  • To review recent therapeutic advancements in managing myeloma nephropathy.
  • To offer guidance for the clinical treatment of MM-induced renal failure.

Main Methods:

  • Literature review of recent studies on myeloma nephropathy treatment.
  • Synthesis of current clinical approaches and emerging therapies.

Main Results:

  • Identification of novel treatment strategies targeting light chain production and deposition.
  • Analysis of treatment efficacy in improving renal outcomes in MM patients.

Conclusions:

  • Effective management of myeloma nephropathy is crucial for improving patient prognosis.
  • Continued research into targeted therapies holds promise for better outcomes in MM-related renal failure.